Lessons Learned from SIAs:

Size: px
Start display at page:

Download "Lessons Learned from SIAs:"

Transcription

1 Lessons Learned from SIAs: Magnification of the opportunities and risks to routine immunization programmes 4th Annual Global Immunization Meeting, New York 19 February 2009 Rebecca Martin Communicable Diseases Unit, WHO Regional Office for Europe

2 Objectives To share lessons learned from measles and rubella SIAs in the WHO European Region in 2008 To demonstrate that opportunities and risks to routine immunization programmes, including the introduction of new vaccines, are magnified during SIAs 2

3 SIAs conducted in the context of strengthening health systems Stewardship High-level political commitment Health service delivery Creation of demand for services Deliver safe, effective vaccines Health finances Funding Government supported Creation of resources Capacity building of health care workforce Training in programmatic issues and vaccinology 3

4 Why is it important to monitor safety during SIAs? Immunizing a large population in a short period Vaccines can be given outside of routine health care setting Increased potential for programme errors Perception of increased rate of adverse events following immunization (AEFI) Source: Dina Pfeifer WHO/HQ 4

5 UKRAINE Second largest country in Eastern Europe with largest pool of M&R viruses in circulation in Region from MR SIA to start 26 May 2008 to vaccinate 7.5 million people aged years

6 Anti-vaccination atmosphere prior to SIA Known anti-vaccination groups active in Ukraine CD-ROMs and booklets Lack of evidence MR vaccine is an attack on the genetic fund of Ukraine MOH participated in discussion with antivaccination groups in November 2007 Negative press generated 6

7 Communications activities to address SIA issues: conducted and planned Focus groups conducted among students and health care professionals FAQs developed to address concerns of health care professionals and students Trainings planned for journalists, educators, and health care professionals Radio programmes planned: ask the experts Press conference planned for launch with partners to give positive message 7

8 Events aligning Death of a 17 year-old within 15 hours of receiving MR vaccine in advance to the SIA State prosecutor takes case Multiple commissions Legal aspects of vaccine May 13 May 14 May 16 May 17 May 26 Incomplete case investigation, prophylactic hospitalisation of 156 children from the same school, media outburst Campaign suspended: 116,000 immunized (6-16 May) 8

9 Consequences of events Increase in negative, misinformation from media towards immunization, MOH, SII, WHO and UNICEF Generated mistrust SIA, death and vaccine become prominent public issue Detention and questioning of 1 st Deputy Minister of Health and Chief Sanitary Physician Order to quarantine vaccine 9

10 Extremely Hostile Media Response Unscheduled Vaccination: GENIE SET FREE Deadly Vaccine MOH playing Indian Roulette Vaccination 2008 Gain Freedom From All Ills MR Vaccine You can Trust 10

11 Media coverage in Ukraine on MR SIA and AEFI, 12 May 2 June Number of articles Neutral Positive Negative May Date June 11

12 What was the medical community doing? Widespread confusion Lack of information General mistrust Anti-vaccine position held by several high level persons in academia Pseudo-experts threatened to sue MOH, WHO, UNICEF Pro-vaccination voice barely heard 12

13 MOH response to crisis Limited attempts to state vaccine was safe Suspension/firing of staff 1 st Deputy Minister head of communicable diseases heads of the two institutions involved in vaccine importation Lack of communication with the public Mixed messages 13

14 Partners support Ukraine MOH International technical experts Technical advice on death/hospitalized cases Vaccine storage Pro-immunization media messages High level meetings Geneva: WHO Director General, Ukraine Minister of Health, India Minister of Health Ukraine: RD of WHO/EURO and UNICEF RO 14

15 Risks to routine immunization programme Temporary gains made by anti-vaccination movement Public belief in vaccination as an effective public heath intervention was lost Negative shift in risk perception affecting healthseeking behaviours Threat of measles and rubella outbreak exists 15

16 Strategies to rebuild trust in immunization in Ukraine Conducted KAPB surveys Maintain high level of political advocacy Develop and implement long-term strategy to restore public trust in immunization Scenarios to immunize susceptible population Provide competent and independent sources to media, public and different Government bodies Reinforce technical and communication capacity Build pro-vaccine coalition 16

17 Georgia MR SIA conducted 20 October 12 December Targeted 980,136 persons aged 6-29 years

18 Events aligning AEFIs reported majority in adolescents, predominantly in females the most frequent clinical manifestations: fainting and other symptoms related to emotional reaction (psychogenic) after vaccination AEFIs identified during the SIA do not differ from those of MR campaigns conducted in the European region in

19 The Indian medicine used for the injections of measles and rubella is not registered in Georgia... Rustavi 2 broadcast 22 October 2008 Twelve teenagers were taken to the resuscitation department of the first clinical hospital due to extreme worsening of their health conditions in sequence of the injections.. Measles and rubella virus vaccination started in Georgia 19

20 Immunization coverage by region October 2008, Republic of Georgia Percentage Rustavi 2 story on vaccine from India Tbilisi awara samegrel o imereti kaxeti Sida qartli qv. qartli samcxejavax. guria Date rawa, 20

21 Alia Kronika 28 October 2008 Fatal expe rimen carrie ts wit d out h me on G asles eorgi - r ube an ch lla va ildren ccin Note that Big Scale is the name of the experiment initially determined for the Ukrainian population. As the experiment failed in Ukraine, it was introduced in Georgia. 4th Annual Global Immunization Meeting, New York 19 February e

22 MOH response to AEFIs Intense monitoring and analysis of AEFI National Committee of Experts on AEFI review reports Feedback to sub-national level Frequent positive press releases by MOH and NCDC Extended SIA through 12 Dec % national coverage achieved 22

23 Magnification of the opportunities and risks to routine immunization programmes 23

24 Lessons learned from SIAs Political commitment and trust are key Conduct a situational analysis: Knowledge, attitudes, practices, and beliefs of health care professionals and general population Anti-vaccine movement AEFI surveillance must be operational and risk management strategy developed prior to SIA or introduction of new vaccine Develop a preventive communication plan Educate and work with the media Document and share experiences among countries and Regions 24

25 Source: Dina Pfeifer WHO/HQ 19 February th Annual Global Immunization Meeting, New York 25

26 Acknowledgements Ministries of Health Ukraine Georgia WHO Country Offices UNICEF Country Offices WHO Regional Office UNICEF Regional Office UNICEF Supply Division Yalda Momeni WHO Headquarters Dina Pfeifer Peter Strebel Nora Dellapiane de Rey Patrick Zuber UNICEF Headquarters Dragoslav Popovic Edward Hoekstra US CDC Steve Wassilak Nino Khetsuriani Amra Uzicanin 26

27 Thank you

28 Focus groups conducted Health care professionals: Why vaccinate 2 years after the epidemic? Did the vaccine pass clinical trials? Where has it been used? What complications occurred afterwards? High school and university students: Why vaccinate when there was a large outbreak? Is there any risk of mutations for me or my children if I get vaccinated? Where has vaccine been used before are we going to serve as lab animals? Can we refuse vaccination? 28

Back to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office

Back to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office Back to Basics: Regional Progress Towards Measles and Rubella Elimination and Introduction of New Vaccines WHO European Regional Office SAGE, Geneva 27 October 2009 Rebecca Martin Targeted Diseases and

More information

Strategy and documentation of the measles and rubella elimination in the WHO Regional Office for Europe

Strategy and documentation of the measles and rubella elimination in the WHO Regional Office for Europe Strategy and documentation of the measles and rubella elimination in the WHO Regional Office for Europe Progress Toward Rubella Elimination and CRS Prevention in Europe February 8-10, 2012; Rome, Italy

More information

Expanded Programme on Immunization

Expanded Programme on Immunization Expanded Programme on Immunization Expanded Programme on Immunization has been implementing the reduction of morbidity and mortality due to vaccine preventable diseases among the children aged 1 to 5 years

More information

Ensuring the quality of polio outbreak response activities: A rationale and guide for 3 month, quarterly and 6 month independent assessments

Ensuring the quality of polio outbreak response activities: A rationale and guide for 3 month, quarterly and 6 month independent assessments Ensuring the quality of polio outbreak response activities: A rationale and guide for 3 month, quarterly and 6 month independent assessments Introduction While polio exists anywhere, countries with low

More information

Report to the. GAVI Alliance Board June 2013

Report to the. GAVI Alliance Board June 2013 Report to the GAVI Alliance Board 11-12 June 2013 Subject: Report of: Authored by: Risk Management Update Helen Evans, Deputy CEO Ciara Goldstein, Analyst, Performance Management and Adrien de Chaisemartin,

More information

Update on Implementation of NUV. Carsten Mantel WHO/FCH/IVB/EPI

Update on Implementation of NUV. Carsten Mantel WHO/FCH/IVB/EPI Update on Implementation of NUV Carsten Mantel WHO/FCH/IVB/EPI Introduction of New Vaccines The continuum of activity REGULATORY NORMS & STANDARDS VACCINE SUPPLY PROCUREMENT PRICING FINANCING SURVEILLANCE

More information

Measles and Rubella Initiative Outbreak Response Fund Standard Operating Procedures, effective 01 April 2017

Measles and Rubella Initiative Outbreak Response Fund Standard Operating Procedures, effective 01 April 2017 Measles and Rubella Initiative Outbreak Response Fund Standard Operating Procedures, effective 01 April 2017 A. Introduction In June 2012, the Gavi Board approved $55 million US for measles outbreak response

More information

Addressing Complacency, Convenience and Confidence

Addressing Complacency, Convenience and Confidence Combating vaccine-preventable diseases in the European Region: focus on Measles Elimination Addressing Complacency, Convenience and Confidence Robb Butler VPI/DCE WHO Regional Office for Europe WHO European

More information

WHO position paper on rubella vaccines

WHO position paper on rubella vaccines WHO position paper on rubella vaccines Progress Toward Rubella Elimination And CRS Prevention in Europe February 2012 10-8 Rome, Italy Peter Strebel, WHO and Susan Reef, CDC Rubella Vaccines WHO Position

More information

Challenges of building a new vaccine delivery platform for LMICs

Challenges of building a new vaccine delivery platform for LMICs Challenges of building a new vaccine delivery platform for LMICs Terri B. Hyde, MD MPH Immunizations Systems Branch, GID, CDC 23 March 2017 Immunization in the Elderly Geneva, Switzerland What has been

More information

An aggressive approach for measles outbreak among adolescents in Barranquilla, Colombia, 2011

An aggressive approach for measles outbreak among adolescents in Barranquilla, Colombia, 2011 Closing immunity gaps in older children and adults towards measles and rubella elimination: Lessons learned and challenges. Siena, Italy, May 10-11 2016 An aggressive approach for measles outbreak among

More information

The State of Measles and Rubella in the WHO European Region

The State of Measles and Rubella in the WHO European Region The State of Measles and Rubella in the WHO European Region Mark Muscat Vaccine-preventable Diseases and Immunization Rome, Italy, 16-17 June 2016 All six WHO Regions have measles elimination goals 2 Annual

More information

How to present the European Vaccine Action Plan (EVAP)

How to present the European Vaccine Action Plan (EVAP) How to present the European Vaccine Action Plan 2015-2020 () HOW TO USE THIS DOCUMENT By adopting the European Vaccine Action Plan 2015-2020 () in September 2014, all Member States of the WHO European

More information

Fifth report of Committee A

Fifth report of Committee A SIXTY-EIGHTH WORLD HEALTH ASSEMBLY (Draft) A68/73 26 May 2015 Fifth report of Committee A (Draft) Committee A held its twelfth and thirteenth meetings on 25 May 2015 under the chairmanship of Dr Eduardo

More information

Midterm Review of the Global Measles and Rubella Strategic Plan W. A. Orenstein, MD SAGE Geneva, 19 October 2016

Midterm Review of the Global Measles and Rubella Strategic Plan W. A. Orenstein, MD SAGE Geneva, 19 October 2016 Midterm Review of the Global Measles and Rubella Strategic Plan 2012 2020 W. A. Orenstein, MD SAGE Geneva, 19 October 2016 1 Outline Strategic Plan 2012-2020 Progress toward milestones and goals Objectives

More information

WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network

WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network Tokyo, July 2009 World Bank Response to A(H1N1) Influenza A(H1N1) Global Health and Risks

More information

Measles Containing Vaccines. UNICEF Supply Division Industry Consultation Meeting January 2012

Measles Containing Vaccines. UNICEF Supply Division Industry Consultation Meeting January 2012 Measles Containing Vaccines UNICEF Supply Division Industry Consultation Meeting 25-26 January 2012 Content Measles monovalent vaccine: Programme Updates and Procurement Overview Measles and Rubella vaccine:

More information

Oral Polio Vaccine Supply Outlook. UNICEF Supply Division

Oral Polio Vaccine Supply Outlook. UNICEF Supply Division Oral Polio Vaccine Supply Outlook UNICEF Supply Division May 2017 Oral Polio Vaccine Supply Outlook May 2017 This note provides updated information on 2016 and 2017 oral polio vaccine supply and demand,

More information

The challenge of vaccine hesitancy in the European Union

The challenge of vaccine hesitancy in the European Union The challenge of vaccine hesitancy in the European Union Michael Sulzner AIM SEMINAR Vaccine hesitancy, a global trend which threatens public health 11 December 2017, Brussels Outline - Competence - Political

More information

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006

Mid-term Review of the UNGASS Declaration of. Commitment on HIV/AIDS. Ireland 2006 Mid-term Review of the UNGASS Declaration of Commitment on HIV/AIDS Ireland 2006 Irish Role in Global Response Just as the HIV/AIDS epidemic is a global threat, addressing the challenge of the epidemic

More information

CLOSING MR IMMUNITY GAPS EXPERIENCES FROM THE REGIONS MALAWI. Geoffrey Zimkambani Chirwa EPI Manager

CLOSING MR IMMUNITY GAPS EXPERIENCES FROM THE REGIONS MALAWI. Geoffrey Zimkambani Chirwa EPI Manager CLOSING MR IMMUNITY GAPS EXPERIENCES FROM THE REGIONS MALAWI Geoffrey Zimkambani Chirwa EPI Manager Outline (1) Background of the NIP and epidemiology of MR How did you diagnose that older teenager/adult

More information

Appendix F. Results of the Electronic Survey of World Bank Task Team Leaders

Appendix F. Results of the Electronic Survey of World Bank Task Team Leaders Appendix F. Results of the Electronic Survey of World Bank Task Team Leaders 1. An electronic survey was administered in April-May 2013 to 112 World Bank Task Team Leaders of Bank-supported health projects

More information

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services United Nations Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services Distr.: General 25 April 2014 Original:

More information

Polio and measles control: opportunities and threats for health systems

Polio and measles control: opportunities and threats for health systems Polio and measles control: opportunities and threats for health systems USAID Global Health Mini University March 4, 2016 Dr. Craig Burgess, JSI OVERVIEW Polio and measles: an overview Control strategies

More information

Opinion. Vaccination Programmes and Health Systems in the EU. Expert Panel on Effective Ways of Investing in Health

Opinion. Vaccination Programmes and Health Systems in the EU. Expert Panel on Effective Ways of Investing in Health Opinion Vaccination Programmes and Health Systems in the EU Expert Panel on Effective Ways of Investing in Health Brussels, 13 September 2018 Expert Panel on Investing in Health Access to innovative medicines

More information

Effects of the Global Fund on the health system

Effects of the Global Fund on the health system Ukraine: Effects of the Global Fund on the health system Tetyana Semigina 27 Abstract Ukraine has one of the most rapidly growing HIV/AIDS epidemics in Europe, with estimated numbers of people living with

More information

Human Papillomavirus Vaccination Programme in Malaysia

Human Papillomavirus Vaccination Programme in Malaysia 2016/SOM3/HWG-LSIF/WKSP/010 Session Human Papillomavirus Vaccination Programme in Malaysia Submitted by: Malaysia Accelerating Action on Human Papillomavirus and Cervical Cancer Prevention and Control

More information

Polio post-certification strategy

Polio post-certification strategy 1 Polio post-certification strategy SAGE Meeting, Geneva, 17 April 2018 Michel Zaffran, Director, Polio Eradication, WHO On Behalf o the GPEI Polio Eradication and Endgame Strategy 1. Poliovirus detection

More information

Thank you for joining, the M&RI webinar will begin shortly

Thank you for joining, the M&RI webinar will begin shortly Thank you for joining, the M&RI webinar will begin shortly Please mute your phone or microphone Please do not place the call on hold If you have difficulty with the quality of the connection then here

More information

PLANNING & EVALUATION WORKBOOK

PLANNING & EVALUATION WORKBOOK 25 April-2 May 2015 PLANNING & EVALUATION WORKBOOK WEB: www.paho.org/vwa FACEBOOK: https://www.facebook.com/pahowho TWITTER: https://twitter.com/pahowho VWA 2015 PLANNING INTRODUCTION Originally launched

More information

PLANNING & EVALUATION WORKBOOK. WEB: FACEBOOK:

PLANNING & EVALUATION WORKBOOK. WEB:   FACEBOOK: PLANNING & EVALUATION WORKBOOK WEB: www.paho.org/vwa FACEBOOK: https://www.facebook.com/paho.im TWITTER: http://twitter.com/opspaho_vac INTRODUCTION Originally launched in 2003, Vaccination Week in the

More information

Combating HIV/AIDS and stigmatisation

Combating HIV/AIDS and stigmatisation Goal and objectives Indicators Sources of verification Programme goal Health of vulnerable people has improved. Programme objective Georgian Red Cross has strengthened capacity to improve health of vulnerable

More information

Introduction to Measles a Priority Vaccine Preventable Disease (VPD) in Africa

Introduction to Measles a Priority Vaccine Preventable Disease (VPD) in Africa Introduction to Measles a Priority Vaccine Preventable Disease (VPD) in Africa Nigeria Center for Disease Control Federal Ministry of Health Abuja July 2015 Outline 1. Measles disease 2. Progress towards

More information

WHO Global Strategies in Cervical Cancer Prevention and Control

WHO Global Strategies in Cervical Cancer Prevention and Control WHO Global Strategies in Cervical Cancer Prevention and Control Dr. JM. DANGOU WHO-AFRO 1 Regional Conference on New Opportunities and Innovations in Cervical Cancer prevention Cervical Cancer burden Age-standardised

More information

Measles and rubella monitoring January 2015

Measles and rubella monitoring January 2015 Measles and rubella monitoring January 215 Reporting on January December 214 surveillance data and epidemic intelligence data to the end of January 215 Main developments Measles During the 12-month period

More information

GAVI S CONTINUED ROLE IN YELLOW FEVER CONTROL

GAVI S CONTINUED ROLE IN YELLOW FEVER CONTROL GAVI S CONTINUED ROLE IN YELLOW FEVER CONTROL BOARD MEETING Michael F Thomas, Abidjan, Côte d Ivoire Reach every child www.gavi.org EVOLVING CONTEXT: THREATS AND OPPORTUNITIES Yellow fever is a global

More information

Measles Elimination in NZ. Dr Tom Kiedrzynski Principal Adviser, Communicable diseases, Ministry of Health

Measles Elimination in NZ. Dr Tom Kiedrzynski Principal Adviser, Communicable diseases, Ministry of Health Measles Elimination in NZ Dr Tom Kiedrzynski Principal Adviser, Communicable diseases, Ministry of Health Presentation Outline International background WHO requirements Overview of the measles situation

More information

Communicable Disease Control in Complex Emergencies

Communicable Disease Control in Complex Emergencies Communicable Disease Control in Complex Emergencies Magnitude of the problem Communicable diseases are the major killers in complex emergencies. Death rates among refugees and displaced persons over 60

More information

MINISTRY OF HEALTH UNICEF

MINISTRY OF HEALTH UNICEF page 1 / 5 page 2 / 5 ministry of health unicef pdf UNICEF is fully committed to working with the Government of India to ensure that each child born in this country gets the best start in life, thrives

More information

Egypt Success Story In Combating Avian Influenza

Egypt Success Story In Combating Avian Influenza Egypt Success Story In Combating Avian Influenza Wild bird situation Approximately 4 millions migratory birds pass over Egypt. About 500,000 migratory birds spend a period of time in 35 Wetland Areas Highly

More information

Poliomyelitis eradication in the WHO European Region

Poliomyelitis eradication in the WHO European Region Provisional agenda item 6(i) EUR/RC60/16 (+EUR/RC60/Conf.Doc./9) 23 July 2010 101614 ORIGINAL: ENGLISH Poliomyelitis eradication in the WHO European Region WHO Regional Committee for Europe Sixtieth session

More information

Legislative Approaches to Immunization Across the European Region

Legislative Approaches to Immunization Across the European Region Legislative Approaches to Immunization Across the European Region December 2018 1 OUR MISSION To make life-changing vaccines more accessible, enable innovation & expand immunization across the globe. 2

More information

PROGRESS ON THE EASTERN AND SOUTHERN AFRICA MINISTERIAL COMMITMENT. Ms. Mwansa Njelesani-Kaira, UNESCO - RST, ESA

PROGRESS ON THE EASTERN AND SOUTHERN AFRICA MINISTERIAL COMMITMENT. Ms. Mwansa Njelesani-Kaira, UNESCO - RST, ESA PROGRESS ON THE EASTERN AND SOUTHERN AFRICA MINISTERIAL COMMITMENT Ms. Mwansa Njelesani-Kaira, UNESCO - RST, ESA EARLY PREGNANCY AMONG GIRLS AGE 15-19 Pregnancy clearly means the end of education for many

More information

Global Measles Control & Outbreak Risk in the US

Global Measles Control & Outbreak Risk in the US Global Measles Control & Outbreak Risk in the US Jeffrey S. Duchin, MD Chief, Communicable Disease Epidemiology & Immunization Section Public Health - Seattle & King County Professor in Medicine, Division

More information

National Rift Valley Fever Contingency Plan

National Rift Valley Fever Contingency Plan National Rift Valley Fever Contingency Plan Dr Austine Bitek Zoonotic Disease Unit Ministry of Agriculture, Livestock and Fisheries Rift Valley Fever Inter Regional Conference Djibouti, 21 23 April 2015

More information

Highlighting in the WHO European Region:

Highlighting in the WHO European Region: No. 23(April 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European

More information

Global reductions in measles mortality and the risk of measles resurgence

Global reductions in measles mortality and the risk of measles resurgence Global reductions in measles mortality 2000 2008 and the risk of measles resurgence Measles is one of the most contagious human diseases. In 1980 before the use of measles vaccine was widespread, there

More information

Report. 10 th Meeting of the Expert Review Committee (ERC) on Polio Eradication in Nigeria

Report. 10 th Meeting of the Expert Review Committee (ERC) on Polio Eradication in Nigeria Report 10 th Meeting of the Expert Review Committee (ERC) on Polio Eradication in Nigeria Kano, Nigeria 12-13 July 2006 Executive Summary The 10 th Expert Review Committee (ERC) met in Kano on 12-13 July

More information

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

Highlighting in the WHO European Region: Summary. No. 21(February 2012) No. 21(February 2012) Issue 15, April 2011 A monthly publication on vaccine preventable diseases and immunization data and analysis Highlighting in the WHO European Region: Update on measles in the European

More information

Gavi Alliance Strategy : Goal level indicators and disease dashboard

Gavi Alliance Strategy : Goal level indicators and disease dashboard Gavi Alliance Strategy 2016-2020: Goal level indicators and disease dashboard BOARD MEETING Peter Hansen and Hope Johnson 10-11 June 2015, Geneva Reach every child www.gavi.org Strategic enablers Goal-level

More information

Çeşme Izmir, Turkey, September 2013

Çeşme Izmir, Turkey, September 2013 Regional Committee for Europe Sixty-third session Çeşme Izmir, Turkey, 16 19 September 2013 İZKA/ Tamer Hartevioğlu Progress report on measles and rubella elimination and the package for accelerated action

More information

Sudan EPI Benefits From Polio Eradication Program

Sudan EPI Benefits From Polio Eradication Program Federal Ministry of Health Primary Health Care Maternal and Child Health Expanded Program on Immunization Sudan EPI Benefits From Polio Eradication Program Polio Legacy Planning and Implementation Workshop

More information

3. CONCLUSIONS AND RECOMMENDATIONS

3. CONCLUSIONS AND RECOMMENDATIONS 3. CONCLUSIONS AND RECOMMENDATIONS 3.1 Polio Endgame Strategy Conclusions 1. The TAG welcomes the RCC conclusion that Western Pacific Region maintains its polio-free status, and commends China for the

More information

Meeting of the Polio Oversight Board (call) 1 September :00 am 11:00 am Meeting Minutes

Meeting of the Polio Oversight Board (call) 1 September :00 am 11:00 am Meeting Minutes Participants: Dr. Tom Frieden (CDC, POB Chair) Mr. John Germ (Rotary) Dr. Chris Elias (BMGF) Dr. Margaret Chan (WHO) Mr. Tony Lake (UNICEF) Meeting of the Polio Oversight Board (call) 1 September 2016

More information

Targeted Diseases and Immunization. Strategic plan

Targeted Diseases and Immunization. Strategic plan Targeted Diseases and Immunization Strategic plan 2008-2013 Communicable Diseases Unit WHO Regional Office for Europe Mission To provide technical support to WHO European Region Member States to ensure

More information

Globalization and Health The regional response

Globalization and Health The regional response Zsuzsanna Jakab Director European Centre for Disease Prevention and Control (ECDC) IBA Annual Meeting Anthrax, SARS and Bioweaponry Is Globalisation Bad for Your Health? 28 September 2005, Prague Globalization

More information

World Immunization Week 2013

World Immunization Week 2013 CAMPAIGN ESSENTIALS World Immunization Week 2013 Protect your world get vaccinated World Health Organization 2013. All rights reserved. Document number: WHO/World-Immunization-Week/2013.1 This document

More information

Rotavirus Vaccinating in Africa Ghana Case Study. GE Armah Noguchi Memorial Institute for Medical Research ROTA Council

Rotavirus Vaccinating in Africa Ghana Case Study. GE Armah Noguchi Memorial Institute for Medical Research ROTA Council Rotavirus Vaccinating in Africa Ghana Case Study GE Armah Noguchi Memorial Institute for Medical Research ROTA Council Rotavirus vaccine introductions in Africa Eleven African countries approved by Gavi

More information

2013 British Columbia/Washington State Cross Border Infectious Disease/Pandemic Tabletop Exercise

2013 British Columbia/Washington State Cross Border Infectious Disease/Pandemic Tabletop Exercise 2013 British Columbia/Washington State Cross Border Infectious Disease/Pandemic Tabletop Exercise After-Action Report Dec 2013 1 EXERCISE OVERVIEW Exercise Name 2013 British Columbia/Washington State Cross

More information

GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights

GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION. (indicator G2.2) Highlights GOAL 2: ACHIEVE RUBELLA AND CRS ELIMINATION (indicator G2.2) Highlights As of December 2014, 140 Member States had introduced rubella vaccines; coverage, however, varies from 12% to 94% depending on region.

More information

Progress reports on selected Regional Committee resolutions:

Progress reports on selected Regional Committee resolutions: REGIONAL COMMITTEE Provisional Agenda item 4.7.2 Sixty-sixth Session SEA/RC66/14 SEARO, New Delhi, India 10 13 September 2013 19 July 2013 Progress reports on selected Regional Committee resolutions: 2012:

More information

GAVI partners Forum, Dar es Salaam, Tanzania December 5-7, 2012

GAVI partners Forum, Dar es Salaam, Tanzania December 5-7, 2012 GAVI partners Forum, Dar es Salaam, Tanzania December 5-7, 2012 ADRESSING CHALLENGES TO SUSTAINABLE NEW VACCINE INTRODUCTION: PERSPECTIVE FROM MONGOLIA N.UDVAL, MD, Sc D MINISTER OF HEALTH MONGOLIA CONTENT

More information

Gavi s strategic framework 22 June 2016

Gavi s strategic framework 22 June 2016 Gavi s 2016 2020 strategic framework 22 June 2016 Gavi 2000-2015 Gavi 3.0 Gavi 2.0 250 million children immunised Gavi 1.0 90m children immunised 200 million children immunised 2000 2005 2006 2010 2011

More information

BUILDING TRUST, MANAGING RISK: VACCINE CONFIDENCE AND HUMAN PAPILLOMAVIRUS VACCINATION

BUILDING TRUST, MANAGING RISK: VACCINE CONFIDENCE AND HUMAN PAPILLOMAVIRUS VACCINATION BUILDING TRUST, MANAGING RISK: VACCINE CONFIDENCE AND HUMAN PAPILLOMAVIRUS VACCINATION Associate Professor Kristine Macartney Deputy Director, National Centre for Immunisation Research & Surveillance www.ncirs.usyd.edu.au

More information

SPEAKING NOTES OF H.E. DR. AARON MOTSOALEDI, MINISTER OF HEALTH OF REPUBLIC OF SOUTH AFRICA AT THE GLOBAL HIV

SPEAKING NOTES OF H.E. DR. AARON MOTSOALEDI, MINISTER OF HEALTH OF REPUBLIC OF SOUTH AFRICA AT THE GLOBAL HIV SPEAKING NOTES OF H.E. DR. AARON MOTSOALEDI, MINISTER OF HEALTH OF REPUBLIC OF SOUTH AFRICA AT THE GLOBAL HIV PREVENTION COALITION MEETING, 10 OCTOBER2017 I have said many times, and wish to repeat, that

More information

The outlook for hundreds of thousands adolescents is bleak.

The outlook for hundreds of thousands adolescents is bleak. Adolescents & AIDS Dr. Chewe Luo Chief HIV/AIDS, UNICEF Associate Director, Programmes Division 28/11/17 Professor Father Micheal Kelly Annual Lecture on HIV/AIDS Dublin, Ireland The outlook for hundreds

More information

Progress in maternal and child health: Uzbekistan and WHO European Region

Progress in maternal and child health: Uzbekistan and WHO European Region Progress in maternal and child health: Uzbekistan and WHO European Region The National Model of Maternal and Child Health Protection in Uzbekistan: Zsuzsanna Jakab WHO Regional Director for Europe UZBEKISTAN

More information

DRC EBOLA SITUATION REPORT 16 May 2018

DRC EBOLA SITUATION REPORT 16 May 2018 Democratic Republic of the Congo Ebola Situation Report 16 May, 2018 SITUATION IN NUMBER Highlights One of three suspected cases in Wangata Health Zone in Mbandaka, the capital of Equator province with

More information

EBOLA VIRUS DISEASE. Page 1

EBOLA VIRUS DISEASE. Page 1 EBOLA VIRUS DISEASE Page 1 EBOLA VIRUS DISEASE Date of issue: 7 August 2018 Data as reported by: 5 August 2018 1. Situation update Cases 43 Deaths CFR 34 79% On 1 August 2018, the Ministry of Health of

More information

FISCAL YEAR 2020 APPROPRIATIONS REQUESTS (updated ) USAID Global Health Programs (GHP) and State Department

FISCAL YEAR 2020 APPROPRIATIONS REQUESTS (updated ) USAID Global Health Programs (GHP) and State Department FISCAL YEAR 2020 APPROPRIATIONS REQUESTS (updated 2.13.19) Contact: Brian Massa, Senior Manager for Global Health Advocacy, Shot@Life (bmassa@unfoundation.org) USAID Global Health Programs (GHP) and State

More information

Communities tackling fgm in the uk

Communities tackling fgm in the uk Communities tackling fgm in the uk The Tackling Female Genital Mutilation Initiative (2010-2016) Evaluation Summary The Tackling Female Genital Mutilation Initiative (TFGMI) supported community based organisations

More information

Table 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210

Table 1: Basic information Total population 25,030, (per 100,000 LB) Division/Province/State/Region 11. District 210 EPI history EPI launched in 980 HepB vaccine introduced in 003 AD syringes introduced in 003 HepB birth dose introduced in 004 DTP-HepB vaccine introduced in 006 MCV introduced in 008 DTP-Hib-HepB vaccine

More information

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( )

Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections ( ) Regional Committee for Europe 65th session EUR/RC65/Inf.Doc./3 Vilnius, Lithuania, 14 17 September 2015 2 September 2015 150680 Provisional agenda item 3 ORIGINAL: ENGLISH Global health sector strategies

More information

Measles and Rubella Global Update SAGE 19 October 2017

Measles and Rubella Global Update SAGE 19 October 2017 Measles and Rubella Global Update SAGE 19 October 2017 Alya Dabbagh WHO HQ, IVB/EPI Global update Overview Regional progress and challenges M&RI Midterm Review updates Economics of measles and rubella

More information

Polio and routine immunisation Alan Brooks

Polio and routine immunisation Alan Brooks Polio and routine immunisation Alan Brooks Geneva, Switzerland, Background 1 History of polio eradication World Health Assembly Resolution 400 Previous eradication targets Polio cases (thousands) 300 200

More information

1-2 December 2015 Geneva, Switzerland. Anticipating emerging infectious disease epidemics

1-2 December 2015 Geneva, Switzerland. Anticipating emerging infectious disease epidemics 1-2 December 2015 Geneva, Switzerland Anticipating emerging infectious disease epidemics Session 1 Summary of the meeting Session 1: learning from the past (1) Preparedness (inter-epidemic period) is a

More information

Polio Transition Planning: Risks and opportunities of transitioning resources to non-polio public health interventions

Polio Transition Planning: Risks and opportunities of transitioning resources to non-polio public health interventions Polio Transition Planning: Risks and opportunities of transitioning resources to non-polio public health interventions Global Polio Partners Group (PPG) meeting June 26, 2017 Underlying premise: Transition

More information

What is this document and who is it for?

What is this document and who is it for? Measles and Rubella Initiative s Standard Operating Procedures for Accessing Support for Measles and Rubella Supplementary Immunization Activities During 2016 In the context of measles and rubella elimination

More information

Children and AIDS Fourth Stocktaking Report 2009

Children and AIDS Fourth Stocktaking Report 2009 Children and AIDS Fourth Stocktaking Report 2009 The The Fourth Fourth Stocktaking Stocktaking Report, Report, produced produced by by UNICEF, UNICEF, in in partnership partnership with with UNAIDS, UNAIDS,

More information

IMMUNIZATION IN HUMANITARIAN RESPONSE and PARTNER COORDINATION. GAVI Board - 13 June 2017, Geneva

IMMUNIZATION IN HUMANITARIAN RESPONSE and PARTNER COORDINATION. GAVI Board - 13 June 2017, Geneva IMMUNIZATION IN HUMANITARIAN RESPONSE and PARTNER COORDINATION GAVI Board - 13 June 2017, Geneva SCALE OF HUMANITARIAN RESPONSE NEEDS Strengthened HC System Improved financing Cluster Approach HUMANITARIAN

More information

Preventing disease Promoting and protecting health

Preventing disease Promoting and protecting health Preventing disease Promoting and protecting health CONTENTS Context Global Health Security what is it? Health security the perfect storm Regional Health Security what is it? Caribbean Regional Health Security:

More information

SPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA. 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m.

SPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA. 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m. SPECIAL EVENT ON PHILANTHROPY AND THE GLOBAL PUBLIC HEALTH AGENDA 23 February 2009, United Nations, New York Conference Room 2, 3:00 p.m. 6:00 p.m. ISSUES NOTE Improving the Health Outcomes of Women and

More information

Measles-Containing Vaccines: Supply & Demand Outlook. UNICEF Supply Division

Measles-Containing Vaccines: Supply & Demand Outlook. UNICEF Supply Division MeaslesContaining Vaccines: & Outlook UNICEF Division May 2014 0 MeaslesContaining Vaccines (MCV): & Outlook May 2014 This update reports on anticipated 2014 MCV demand and supply availability. Unconfirmed

More information

The Future of Health in Africa

The Future of Health in Africa The Future of Health in Africa Organised by the Global Health Centre at the Graduate Institute, the Chatham House and the International Federation of Pharmaceutical Manufacturers and Associations Biographies

More information

Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues

Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues EXECUTIVE BOARD EB44/ 44th session December 08 Provisional agenda item 5.8 Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues Ending tuberculosis Report

More information

Public health dimension of the world drug problem

Public health dimension of the world drug problem SEVENTIETH WORLD HEALTH ASSEMBLY A70/29 Provisional agenda item 15.3 27 March 2017 Public health dimension of the world drug problem Report by the Secretariat 1. The Executive Board at its 140th session

More information

Message from. Dr Samlee Plianbangchang Regional Director, WHO South-East Asia. At the. Regional Review Meeting on Immunization

Message from. Dr Samlee Plianbangchang Regional Director, WHO South-East Asia. At the. Regional Review Meeting on Immunization Message from Dr Samlee Plianbangchang Regional Director, WHO South-East Asia At the Regional Review Meeting on Immunization 19-23 July 2010 WHO/SEARO, New Delhi Regional Review Meeting on Immunization

More information

H1N1 PANDEMIC: LESSONS LEARNT VIEWS FROM A COUNTRY RECEIVING DONATED PRODUCTS

H1N1 PANDEMIC: LESSONS LEARNT VIEWS FROM A COUNTRY RECEIVING DONATED PRODUCTS H1N1 PANDEMIC: LESSONS LEARNT VIEWS FROM A COUNTRY RECEIVING DONATED PRODUCTS Delese Mimi Darko Head of Pharmacovigilance and Clinical Trials Food and Drugs Board, Ghana OUTLINE Ghana s Healthcare system

More information

Yellow fever. Key facts

Yellow fever. Key facts From: http://www.who.int/en/news-room/fact-sheets/detail/yellow-fever WHO/E. Soteras Jalil Yellow fever 14 March 2018 Key facts Yellow fever is an acute viral haemorrhagic disease transmitted by infected

More information

UNICEF s Response to the Ebola Crisis. Presenta(on to the Execu(ve Board, Informal Session, 11 September 2014

UNICEF s Response to the Ebola Crisis. Presenta(on to the Execu(ve Board, Informal Session, 11 September 2014 UNICEF s Response to the Ebola Crisis Presenta(on to the Execu(ve Board, Informal Session, 11 September 2014 Overview Over 2,200+ deaths and over 4,200 confirmed / probable cases in Guinea, Sierra Leone,

More information

Table 1: Basic information 2017

Table 1: Basic information 2017 EPI history EPI launched in 978 OPV and MCV introduced in 987 AD syringes introduced in 00 HepB vaccine introduced in 003 MCV introduced partially in 008 and made available nationwide in 0 DTP-Hib-HepB

More information

Copenhagen, Denmark, September August Malaria

Copenhagen, Denmark, September August Malaria Regional Committee for Europe 64th session EUR/RC64/Inf.Doc./5 Copenhagen, Denmark, 15 18 September 2014 21 August 2014 140602 Provisional agenda item 3 ORIGINAL: ENGLISH Malaria Following the support

More information

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services United Nations DP/FPA/CPD/MDA/3 Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services Distr.: General 3 July

More information

Meeting on setting the immunization agenda through advocacy and communications

Meeting on setting the immunization agenda through advocacy and communications Report of the meeting on setting the immunization agenda through advocacy and communication convened in London on 16-17 January 2008 and held jointly by the United Kingdom Department of Health and the

More information

Understanding your epidemic: WHO tools for hepatitis surveillance

Understanding your epidemic: WHO tools for hepatitis surveillance . Understanding your epidemic: WHO tools for hepatitis surveillance Dr Antons Mozalevskis / WHO Regional Office for Europe Dr Yvan Hutin / Global Hepatitis Programme, WHO Headquarters 25 October 2018,

More information

Viral Hepatitis Burden and Policy Directions in the European Region of WHO

Viral Hepatitis Burden and Policy Directions in the European Region of WHO Viral Hepatitis Burden and Policy Directions in the European Region of WHO Dr Nedret Emiroglu WHO Regional Office for Europe Brussels 14-15 October 2010 Global Burden of Chronic Viral Hepatitis 2.7% all

More information

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services

Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services United Nations Executive Board of the United Nations Development Programme, the United Nations Population Fund and the United Nations Office for Project Services Distr.: General 12 July 2011 Original:

More information

Action plan for the health sector response to viral hepatitis in the WHO European Region

Action plan for the health sector response to viral hepatitis in the WHO European Region Action plan for the health sector response to viral hepatitis in the WHO European Region Dr Antons Mozalevskis WHO Regional Office for Europe VHPB Albania Country Meeting: Tirana, 27-28 October 2016 Chronic

More information

Report to the Board June 2015

Report to the Board June 2015 10-11 June 2015 SUBJECT: Report of: Authored by: Agenda item: Category: MEASLES SUPPLEMENTARY IMMUNISATION ACTIVITIES Hind Khatib-Othman, Managing Director, Country Programmes Khin Devi Aung, Senior Programme

More information

Male Circumcision in Zambia: National Operational Plan for Scale-up

Male Circumcision in Zambia: National Operational Plan for Scale-up Male Circumcision in Zambia: National Operational Plan for Scale-up PEPFAR/WHO/UNAIDS Consultative Meeting Johannesburg, September 28 th, 2012 Dr. Daniel Makawa, National MC Coordinator Background Zambia

More information